MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic, ready-to-use, invariant natural killer T-cell therapies for treating cancer and other immune-mediated diseases. The company is headquartered in New York, New York. Show more

149 FIFTH AVENUE, NEW YORK, NY, UNITED STATES, 10010, New York, NY, 10010, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

56.59M

52 Wk Range

$8.48 - $16.98

Previous Close

$11.09

Open

$11.02

Volume

2,235

Day Range

$10.95 - $11.35

Enterprise Value

51.93M

Cash

8.807M

Avg Qtr Burn

-2.083B

Insider Ownership

59.23%

Institutional Own.

4.01%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AgenT-797 Details Virus-Induced Acute Respiratory Disease Syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AgenT-797 +/- pembrolizumab/nivolumab Details Relapsed/Refractory Solid Tumors, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AgenT-797 + botensilimab/balstilimab Details Gastroesophageal adenocarcinomas, Gastric cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AgenT-797 Details Graft-versus-host disease (GvHD), Immune Disorders	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.